APAC Biotech is a biotechnology startup founded in 2009 with a focus on the research and manufacturing of cell-based immunotherapy treatment for cancer. Their slogan, "A Biotechnology Company focused on Research and Manufacturing of Cell-Based Immunotherapy treatment for Cancer," reflects their dedication to addressing the global issue of cancer. As a company operating in the biotechnology and health care industries, APAC Biotech aims to leverage technology and oncology knowledge to develop therapies that can restore health and save the lives of cancer patients.
General Information
Get notified when APAC Biotech moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track APAC Biotech
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About APAC Biotech
Taxonomy: Immunotherapy, Cancer Research, Cell-based Therapy, Oncology, Dendritic Cell Therapy, Therapeutics, Medical Research, Biopharmaceuticals, Cancer Treatment, Immunology, Cellular Immunotherapy
No funding data available for APAC Biotech yet.
Get notified when APAC Biotech raises fundingAPAC Biotech Alternatives & Competitors
Pioneering the future of cancer immunotherapy with CAR-T cell advancements from academic innovation.
The Twin Cities' only NCI-designated comprehensive cancer center. #UMNCancer
Developing next-generation TIL-based therapies to treat and cure solid tumors.
FAQ About APAC Biotech
Don't just browse. Track.
Signal Tracker monitors APAC Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.